Difference between revisions of "Prostate-specific antigen"
Jump to navigation
Jump to search
| Line 20: | Line 20: | ||
**In another series, 48% of individuals with cancer had a PSAD >0.15 ng/ml.<ref name=pmid22482342>{{Cite journal | last1 = Aganovic | first1 = D. | last2 = Prcic | first2 = A. | last3 = Kulovac | first3 = B. | last4 = Hadziosmanovic | first4 = O. | title = Influence of the prostate volume, prostate specific antigen density and number of biopsy samples on prostate cancer detection. | journal = Med Arh | volume = 66 | issue = 1 | pages = 41-4 | month = | year = 2012 | doi = | PMID = 22482342 }} | **In another series, 48% of individuals with cancer had a PSAD >0.15 ng/ml.<ref name=pmid22482342>{{Cite journal | last1 = Aganovic | first1 = D. | last2 = Prcic | first2 = A. | last3 = Kulovac | first3 = B. | last4 = Hadziosmanovic | first4 = O. | title = Influence of the prostate volume, prostate specific antigen density and number of biopsy samples on prostate cancer detection. | journal = Med Arh | volume = 66 | issue = 1 | pages = 41-4 | month = | year = 2012 | doi = | PMID = 22482342 }} | ||
</ref> | </ref> | ||
**Difference between races have been noted; in those without prostate cancer:<ref name=pmid8998182/> | |||
Difference between races have been noted; in those without prostate cancer:<ref name=pmid8998182/> | ***0.19 +/- 0.03 ng/ml (blacks). | ||
*0.19 +/- 0.03 ng/ml (blacks). | ***0.11 +/- 0.01 ng/ml (whites). | ||
*0.11 +/- 0.01 ng/ml (whites). | |||
Better predictor than (unadjusted) serum PSA for: | Better predictor than (unadjusted) serum PSA for: | ||